Cutoff Assessment for Codeine in Fingerprint Sweat Relative to Oral Fluid, Following Controlled, Oral Administration of Codeine Phosphate Tablets to 40 Healthy Adults
← catalyst calendarSponsored by Intelligent Bio Solutions Inc. (industry) · INBS — their whole pipeline →. With Cliantha Research.
Phase
—
Status
Completed
Study type
Observational
Enrollment
43actual
Sites
1
Country
Canada
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2026-01-28 | actual | When the study began enrolling |
| Primary completion | 2026-02-06 | actual | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2026-02-06 | actual | The whole study's end, after follow-up |
| First posted | 2026-08-10 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-08-10 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Healthy Adult
Intervention
- Device: Determination of codeine phosphate
Primary outcome
what the primary-completion date above is the date OFFingerprint sweat codeine cutoff
measured Within 24 hours of codeine dosing
Permalink · INBS's whole pipeline · Catalyst calendar · Every registered study · What changed